Viveve Med Stock Price, News & Analysis
Company Description
Viveve Med (OTC Link: VIVE) is a publicly traded medical devices company in the Healthcare sector. The company has a market capitalization of $4.3K.
VIVE stock has gained 0.0% over the past year. Shares last traded at $0.0002.
This page provides a comprehensive overview of VIVE stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Viveve Med (VIVE) stock last traded at $0.0002. At a market capitalization of $4.3K, VIVE is classified as a micro-cap stock with approximately 10.7M shares outstanding.
Latest News
Viveve Med has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include clinical trial, earnings, conferences. View all VIVE news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Viveve Med (VIVE) currently stands at 4.1 thousand shares, down 1.0% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has increased by 41.2%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Viveve Med (VIVE) currently stands at 1.0 days, down 85.5% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 58.7% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 7.0 days.
VIVE Company Profile & Sector Positioning
Viveve Med (VIVE) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing VIVE often look at related companies in the same sector, including Pressure Bio (PBIO), Nemaura Med Inc (NMRD), Biolase Inc (BIOLQ), Thermogenesis Holdings Inc (THMO), and TRANSLATE BIO, INC. (TBIO). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate VIVE's relative position within its industry.